Associations between urinary 6‐sulfatoxymelatonin excretion and diabetic vascular complications or arteriosclerosis in patients with type 2 diabetes
Abstract Aims/Introduction There are limited reports on the association between melatonin levels and vascular complications in patients with type 2 diabetes. The aim of this study was to determine the association between urinary 6‐sulfatoxymelatonin, which is a urinary metabolite of melatonin, and d...
Main Authors: | Kenichi Tanaka, Yosuke Okada, Hajime Maiko, Hiroko Mori, Yoshiya Tanaka |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-04-01
|
Series: | Journal of Diabetes Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1111/jdi.13374 |
Similar Items
-
Male-female differences in 6-sulfatoxymelatonin excretion in hypopituitary patients
by: Hugo L. Fideleff, et al.
Published: (2016-02-01) -
Relationship between urinary 6-sulfatoxymelatonin excretion and cancer antigen 125 in women with endometriosis
by: Pei-Yang Hsu, et al.
Published: (2014-11-01) -
Urinary Excretion of 6-Sulfatoxymelatonin, the Main Metabolite of Melatonin, and Mortality in Stable Outpatient Renal Transplant Recipients
by: Anna van der Veen, et al.
Published: (2020-02-01) -
Urinary 6-sulfatoxymelatonin level in girls and its relationship with obesity
by: Jieun Lee, et al.
Published: (2012-09-01) -
Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus
by: Torimoto Keiichi, et al.
Published: (2013-01-01)